QQ客服 官方微博 反馈留言

	Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study(*)
	Robak, Tadeusz; Huang, Huiqiang; Jin, Jie; Zhu, Jun; Liu, Ting; Samoilova, Olga; Pylypenko, Halyna; Verhoef, Gregor; Siritanaratkul, Noppadol; Osmanov, Evgenii
刊名	LEUKEMIA & LYMPHOMA
	2019
卷号	60期号:1
关键词	Mantle cell lymphoma R-CHOP VR-CAP bortezomib LYM-3002 dose intensity
ISSN号	1042-8194
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3619246
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Robak, Tadeusz,Huang, Huiqiang,Jin, Jie,et al. Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study(*)[J]. LEUKEMIA & LYMPHOMA,2019,60(1).
APA	Robak, Tadeusz.,Huang, Huiqiang.,Jin, Jie.,Zhu, Jun.,Liu, Ting.,...&Cavalli, Franco.(2019).Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study(*).LEUKEMIA & LYMPHOMA,60(1).
MLA	Robak, Tadeusz,et al."Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study(*)".LEUKEMIA & LYMPHOMA 60.1(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。